China Pioneer Pharma Holdings Ltd ($1345) - buy or sell? Stock discussion, ideas, forum

China Pioneer Pharma Holdings Ltd

China Pioneer Pharma Holdings Ltd is a marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$1345	HKEx Main Board	KYG2162L1068	Code: 1345

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1345 stock

Share your investment idea or question on China Pioneer Pharma Holdings Ltd stock:

Latest twits on China Pioneer Pharma Holdings Ltd (1345)

No twits yet. Be the first to post!

Have a question about 1345? Ask and other investors will be eager to help you.

Have an idea about 1345? Share it with other investors.

China Pioneer Pharma Holdings Ltd news

22/03/2017 China Pioneer Pharma Holdings Ltd Net Income jumped on 36.2%

29/03/2016 China Pioneer Pharma Holdings Ltd Net Income dropped on 33.4% in 2015 and Revenue decreased on 5.2%

31/03/2015 Eye on China Pioneer Pharma Holdings Ltd as a growth stock: its revenue grew 29.0% and EBITDA 35.7% annually over the last three years

China Pioneer Pharma Holdings Ltd stock price chart

China Pioneer Pharma Holdings Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	570.6	717.8	958.7
EBITDA	97.100	123.2	202.7
Net income	70.435	95.675	186.4
CAPEX	1.339	1.927	0.757
Debt	158.9	338.0	416.2
Cash	114.3	51.356	59.559

China Pioneer Pharma Holdings Ltd news

About China Pioneer Pharma Holdings Ltd

China Pioneer Pharma Holdings Ltd is a marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China.